Fifth Chakra (throat)
Generic Name: fifth chakra (throat)
Brand Names:
Fifth Chakra (throat) 7305
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS Temporarily relieves arrogance, shyness, fear of speaking, inability to express thoughts or feelings, social anxiousness, stubbornness, or fear of being detached from others.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 5 drops up to 4 times per day for up to one month. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Fifth Chakra (throat) used for?▼
INDICATIONS Temporarily relieves arrogance, shyness, fear of speaking, inability to express thoughts or feelings, social anxiousness, stubbornness, or fear of being detached from others.*
Can I take Fifth Chakra (throat) during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Fifth Chakra (throat)?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Hydrocodone Polistirex And Chlorpheniramine Polistirex
hydrocodone polistirex and chlorpheniramine polistirex
11 DESCRIPTION Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension contains hydrocodone, an opioid agonist; and chlorpheniramine, a histamine-1 (H 1 ) receptor antagonist. Each 5 mL of Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release (ER) Suspension contains hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate.
Difluprednate
difluprednate
11 DESCRIPTION Difluprednate ophthalmic emulsion 0.05% is a sterile, topical anti-inflammatory corticosteroid for topical ophthalmic use. The chemical name is 6α,9difluoro-11β,17,21trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate (CAS number 23674-86-4). Difluprednate is represented by the following structural formula: Difluprednate has a molecular weight of 508.56 g/mol, and the empirical formula is C 27 H 34 F 2 O 7 .
Bevacizumab-maly
bevacizumab-maly
11 DESCRIPTION Bevacizumab-maly is a vascular endothelial growth factor inhibitor. Bevacizumab-maly is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab-maly has an approximate molecular weight of 149 kDa. Bevacizumab-maly is produced in a mammalian cell (Chinese Hamster Ovary) expression system.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.